Each year tens of thousands of people are diagnosed with brain and central nervous system tumours. Although the outlook varies greatly between different types of tumour, the current overall survival rates for malignant brain tumours are poor, only 15% of people will survive for five years or more after their diagnosis.
Beating brain tumours by supporting world-class research
Seve set up his Foundation in partnership with Cancer Research UK
in 2009 to raise money for research into brain tumours.
Cancer Research UK is the world’s largest charity dedicated to
cancer research. Their doctors and scientists have contributed to
19 of the top 20 drugs used to treat cancer patients worldwide.
Within the field of brain tumours, Cancer Research UK contributed
to the discovery of the drug Temozolomide. It is used worldwide to treat people with the most common type of brain tumour. Many thousands of people have benefited from treatment with this drug.
Why research is needed
There are around 100 different types of brain tumour and the
tumour type, and where it develops, varies with age. Treatments
that can be offered to patients will vary depending on the location, size and type of tumour. This complexity increases the need for
good quality, broad-ranging research.
With your support we will achieve Seve’s ambition and change the outlook for people diagnosed with brain tumours across the world.